Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Iris Bincovich

Tracked across 4 events · 29 articles · First seen Jul 29, 2026 · Last active Sep 09, 2026

Sentiment
4
Attention
1
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
1 10
Business
Impact: CEO of Innocan Pharma Corporation; commented on the milestone.
Jul 29, 2026 · 7 articles
1 0
Business
Impact: Iris Bincovich, CEO of Innocan Pharma, commented on the results, highlighting the strength of B.I. Sky's business and the impact of tariff policies.
Aug 31, 2026 · 8 articles
1 5
Business
Impact: Iris Bincovich, CEO of Innocan, is listed as a contact but has no direct role in this announcement.
Aug 05, 2026 · 7 articles
1 0
Business
Innocan Pharma Corporation announced on September 9, 2026 its intention to complete a private placement of up to 535,000 units at C$1.87 per unit, for gross proceeds of up to C$1,000,000. Each unit consists of…
Impact: Iris Bincovich is the CEO of Innocan Pharma and is listed as a contact for the offering, representing the company in the private placement.
Sep 09, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Iris Bincovich live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.